StockData
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$21.04−0.92 (-4.19%)

Close on Nov 12, 2026Market cap $411.32MP/E –Yield 0.00%

Earnings

Tectonic Therapeutic's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 5, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q1 FY2025
–
EPS, Q1 FY2025
-$0.93
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Tectonic Therapeutic's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 5, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close–––Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close–––Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close––-$0.93Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025after the close––-$0.84Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024after the close––-$4.34Release
Q1 FY2024ended Mar 31, 2024Jun 20, 2024after the close–––Release
Q1 FY2023ended Mar 31, 2023May 11, 2023before the open––-$0.57Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Tectonic Therapeutic has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Tectonic Therapeutic puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Tectonic Therapeutic filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Results
  3. News
  4. Results
  5. Update
  6. Results
  7. Update
  8. Update
  9. Results
  10. News
  11. News
  12. Results
  13. Results
  14. News
  15. Results

See a number that looks wrong?